Access versus Innovation in Global Healthcare Markets

Access to affordable medicines and healthcare today comes with a dynamic trade-off in terms of potential disincentives for innovation tomorrow. Using theory and techniques from applied microeconomics, Professor Chirantan Chatterjee examines these trade-offs and their welfare implications in research set in United States and Indian healthcare and pharmaceutical markets.

Chirantan Chatterjee is Assistant Professor in the Economics and Public Policy area at the Indian School of Business, where he is also a Research Fellow at the Bharti Institute of Public Policy and Max Institute of Healthcare Management.

Scroll To Top